Speed Was Key for Moderna in Making Covid Vaccine, Says Co-founder
Interactive Video
•
Business
•
University
•
Practice Problem
•
Hard
Wayground Content
FREE Resource
The transcript discusses the development of a vaccine during the early stages of the pandemic, focusing on the speed advantage of Moderna's platform. It highlights the challenges faced by Moderna, a relatively small company, in gaining recognition and support from the U.S. government. The partnership with NIH was crucial in testing the vaccine quickly. The transcript also covers the global demand for the vaccine and the legal constraints that prevented unauthorized distribution, emphasizing the careful governance of the vaccine supply.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What was the role of the NIH in the vaccine development process for Moderna?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
Why was it illegal for Moderna to distribute vaccines during the early stages of the pandemic?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
